BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 20637916)

  • 1. Clinical experience with the second-generation 3f Enable sutureless aortic valve prosthesis.
    Aymard T; Kadner A; Walpoth N; Göber V; Englberger L; Stalder M; Eckstein F; Zobrist C; Carrel T
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):313-6. PubMed ID: 20637916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with the ATS 3f Enable® Sutureless Bioprosthesis.
    Martens S; Sadowski J; Eckstein FS; Bartus K; Kapelak B; Sievers HH; Schlensak C; Carrel T
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):749-55. PubMed ID: 21342776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First clinical experience and 1-year follow-up with the sutureless 3F-Enable aortic valve prosthesis.
    Wendt D; Thielmann M; Buck T; Jánosi RA; Bossert T; Pizanis N; Kamler M; Jakob H
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):542-7. PubMed ID: 18255309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right anterior minithoracotomy aortic valve replacement with a sutureless bioprosthesis: Early outcomes and 1-year follow-up from 2 European centers.
    Vola M; Albertini A; Campisi S; Caprili L; Fuzellier JF; Favre JP; Morel J; Gerbay A
    J Thorac Cardiovasc Surg; 2015 Apr; 149(4):1052-7. PubMed ID: 25648481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sutureless aortic valve bioprothesis '3F/ATS Enable'--4.5 years of a single-centre experience.
    Sadowski J; Kapelak B; Pfitzner R; Bartuś K
    Kardiol Pol; 2009 Aug; 67(8A):956-63. PubMed ID: 19784899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve.
    Treede H; Tübler T; Reichenspurner H; Grube E; Pascotto A; Franzen O; Mueller R; Low R; Bolling SF; Meinertz T; Schofer J
    J Thorac Cardiovasc Surg; 2010 Oct; 140(4):897-903. PubMed ID: 20392455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sutureless aortic valve replacement with the 3f Enable aortic bioprosthesis.
    Martens S; Ploss A; Sirat S; Miskovic A; Moritz A; Doss M
    Ann Thorac Surg; 2009 Jun; 87(6):1914-7. PubMed ID: 19463619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year outcomes of the Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve (TRITON) trial: a prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve System.
    Kocher AA; Laufer G; Haverich A; Shrestha M; Walther T; Misfeld M; Kempfert J; Gillam L; Schmitz C; Wahlers TC; Wippermann J; Mohr FW; Roth M; Skwara A; Rahmanian P; Wiedemann D; Borger MA
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):110-5; discussion 115-6. PubMed ID: 23058665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical performance of a sutureless aortic bioprosthesis: five-year results of the 3f Enable long-term follow-up study.
    Englberger L; Carrel TP; Doss M; Sadowski J; Bartus K; Eckstein FF; Asch FM; Martens S
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1681-7. PubMed ID: 24787699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome.
    Grube E; Schuler G; Buellesfeld L; Gerckens U; Linke A; Wenaweser P; Sauren B; Mohr FW; Walther T; Zickmann B; Iversen S; Felderhoff T; Cartier R; Bonan R
    J Am Coll Cardiol; 2007 Jul; 50(1):69-76. PubMed ID: 17601548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 3f Enable sutureless bioprosthesis: Early results, safeguards, and pitfalls.
    Permanyer E; Estigarribia AJ; Ysasi A; Herrero E; Semper O; Llorens R
    J Thorac Cardiovasc Surg; 2015 Jun; 149(6):1578-83. PubMed ID: 25454912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sutureless aortic valve implantation through an upper v-type ministernotomy: an innovative approach in high-risk patients.
    Concistrè G; Miceli A; Chiaramonti F; Farneti P; Bevilacqua S; Varone E; Solinas M; Glauber M
    Innovations (Phila); 2013; 8(1):23-8. PubMed ID: 23571790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with the 3F stentless aortic bioprosthesis: one-year follow up.
    Linneweber J; Kossagk C; Rogge ML; Dushe S; Dohmen P; Konertz W
    J Heart Valve Dis; 2006 Jul; 15(4):545-8. PubMed ID: 16901052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term follow up with the 3f Enable aortic bioprosthesis: clinical and echocardiographic results.
    Concistrè G; Miceli A; Marchi F; Farneti P; Chiaramonti F; Solinas M; Glauber AG
    J Heart Valve Dis; 2013 Nov; 22(6):817-23. PubMed ID: 24597403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. North American single-center experience with a sutureless aortic bioprosthesis.
    de Varennes B; Lachapelle K; Cecere R; Szczepkowski I; Buithieu J
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):735-742. PubMed ID: 26621319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The St Jude Medical Trifecta aortic pericardial valve: results from a global, multicenter, prospective clinical study.
    Bavaria JE; Desai ND; Cheung A; Petracek MR; Groh MA; Borger MA; Schaff HV
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):590-7. PubMed ID: 23477687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with the ATS 3F stentless aortic bioprosthesis: five years' follow up.
    Linneweber J; Heinbokel T; Christ T; Claus B; Kossagk C; Konertz W
    J Heart Valve Dis; 2010 Nov; 19(6):772-7. PubMed ID: 21214103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sutureless Perceval aortic valve in comparison with the stented Carpentier-Edwards Perimount aortic valve.
    König KC; Wahlers T; Scherner M; Wippermann J
    J Heart Valve Dis; 2014 Mar; 23(2):253-8. PubMed ID: 25076560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of valve-in-valve for severe para-prosthetic leaks due to inadequate transcatheter aortic valve implantation.
    Napodano M; Gasparetto V; Tarantini G; Fraccaro C; Yzeiraj E; Gerosa G; Isabella G; Iliceto S
    Catheter Cardiovasc Interv; 2011 Dec; 78(7):996-1003. PubMed ID: 22114036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mid-term evaluation of Sorin Soprano bioprostheses in patients with a small aortic annulus Vohra HA; Whistance RN; Bolgeri M; Velissaris T; Tsang GM; Barlow CW; Ohri SK
    Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):399-402. PubMed ID: 19952015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.